{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:54:46Z","timestamp":1791561286986,"version":"4.3.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":261,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK Medical Research Council","id":[{"id":"https:\/\/ror.org\/03x94j517","id-type":"ROR","asserted-by":"crossref"}]},{"name":"OptumUK"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The immunosuppressed are poorly represented in disease surveillance and pharmacovigilance dataflows, proving especially consequential during the COVID-19 pandemic. This mixed methods study recruited a panel of immunosuppressed patients (DESTINIES Patient Panel) to quality assure a new digital phenotype for COVID-19 risk in the adult immunosuppressed (DESTINIES phenotype) prior to its implementation in real-world surveillance. Applying their lived experiences, the DESTINIES Patient Panel met to critique the strategy and structure of the provisional phenotype before voting on its adoption in UK disease surveillance. They did so anonymously. This convening was hosted and recorded on Zoom; Google Forms collected panellist feedback and their final ratifying vote. Feedback was inductively content analysed. 33 patients that adhered to the DESTINIES phenotype definition of immunosuppression submitted their feedback and final vote. Despite obtaining expressions of interest, no person with drug-managed HIV participated; this was a significant limitation given their unique positioning in the phenotype. However, 88% of panellists approved the DESTINIES phenotype for adoption in the UK, 91% agreed it represented a step forward for COVID-19 disease surveillance, and 91% agreed to see it trialled in other surveillance pathways (RSV, pneumonia etc.). Panellist feedback was catalogued by themes of \u2018Abandonment\u2019, \u2018Accessibility\u2019, \u2018Accuracy\u2019, and \u2018Omission\u2019. The patient voice is often absent in the dataflows purporting to be in their interest. This is an oversight; certain limitations captured in this exercise were unlikely to have surfaced without patient engagement. The DESTINIES phenotype is made more robust by the collective criticism of expert clinicians and patients alike.<\/jats:p>","DOI":"10.1093\/oxfimm\/iqag015","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:18:05Z","timestamp":1789672685000},"source":"Crossref","is-referenced-by-count":0,"title":["Patients know best: DESTINIES Patient Panel appraisal of a novel, risk-stratified approach to COVID-19 disease surveillance in the adult immunosuppressed"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-714X","authenticated-orcid":false,"given":"Meredith","family":"Leston","sequence":"first","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford, OX2 6GG,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"de Groot","sequence":"additional","affiliation":[{"name":"Dutch Myositis Working Group, Spierziekten Nederland , Lt.Gen van Heutszlaan 6 , Baarn 3743JN,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M","family":"Ord\u00f3\u00f1ez-Mena","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford, OX2 6GG,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F D Richard","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford, OX2 6GG,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Joy","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford, OX2 6GG,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennard Y W","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford , Old Road Campus Research Building, Roosevelt Drive , OX3 7DQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-5470","authenticated-orcid":false,"given":"Benjamin W","family":"Teh","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre , 305 Grattan Street , Melbourne, VIC 3000,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"McInnes","sequence":"additional","affiliation":[{"name":"MVLS College Office, Wolfson Medical School Building, University of Glasgow , University Avenue , Glasgow, G12 8QQ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-2641","authenticated-orcid":false,"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford, OX2 6GG,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026100911163573100_iqag015-B1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.5005\/jp-journals-10071-23908","article-title":"Disease surveillance: the bedrock for control and prevention","volume":"25","author":"Krishna","year":"2021","journal-title":"Indian J Crit Care Med"},{"key":"2026100911163573100_iqag015-B2","doi-asserted-by":"publisher","DOI":"10.17226\/11996","volume-title":"Global Infectious Disease Surveillance and Detection","author":"Institute of Medicine","year":"2007"},{"key":"2026100911163573100_iqag015-B3","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s12325-023-02492-3","article-title":"Safety surveillance during drug development: comparative evaluation of existing regulations","volume":"40","author":"Samara","year":"2023","journal-title":"Adv Ther"},{"key":"2026100911163573100_iqag015-B4","doi-asserted-by":"publisher","DOI":"10.56159\/emergencies-9","volume-title":"Surveillance, Outbreak Detection, and Early Warning","author":"Peh","year":"2024"},{"key":"2026100911163573100_iqag015-B5","author":"WHO","year":"2023"},{"key":"2026100911163573100_iqag015-B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12919-025-00320-w","article-title":"Harnessing the power of artificial intelligence for disease-surveillance purposes","volume":"19","author":"Tornimbene","year":"2025","journal-title":"BMC Proc"},{"key":"2026100911163573100_iqag015-B7","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/bmj.324.7347.1210","article-title":"Education and debate: consent, confidentiality, and the threat to public health surveillance","volume":"324","author":"Verity","year":"2002","journal-title":"BMJ"},{"key":"2026100911163573100_iqag015-B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/jmdh.s125885","article-title":"First, do no harm: institutional betrayal and trust in health care organizations","volume":"10","author":"Smith","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"2026100911163573100_iqag015-B9","doi-asserted-by":"publisher","first-page":"e50421","DOI":"10.2196\/50421","article-title":"Patient and public willingness to share personal health data for third-party or secondary uses: systematic review","volume":"26","author":"Baines","year":"2024","journal-title":"J Med Internet Res"},{"key":"2026100911163573100_iqag015-B10","doi-asserted-by":"publisher","first-page":"100071","DOI":"10.1016\/j.medp.2025.100071","article-title":"Progress and challenges in infectious disease surveillance and early warning","volume":"2","author":"Shen","year":"2025","journal-title":"Med Plus"},{"key":"2026100911163573100_iqag015-B11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1513\/annalsats.201507-415bc","article-title":"Validation of a method to identify immunocompromised patients with severe sepsis in administrative databases","volume":"13","author":"Greenberg","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026100911163573100_iqag015-B12","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.eclinm.2023.101965","article-title":"Vaccines and therapeutics for immunocompromised patients with covid-19","volume":"59","author":"Shoham","year":"2023","journal-title":"eClinicalMed"},{"key":"2026100911163573100_iqag015-B13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13054-018-2079-9","article-title":"Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database","volume":"22","author":"Cortegiani","year":"2018","journal-title":"Critical Care"},{"key":"2026100911163573100_iqag015-B14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s40520-023-02380-4","article-title":"Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic","volume":"35","author":"Bukan","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"2026100911163573100_iqag015-B15","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.cmi.2022.05.005","article-title":"Immunocompromised patients have been neglected in COVID-19 trials: a call for action","volume":"28","author":"Tr\u00f8seid","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2026100911163573100_iqag015-B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13223-022-00679-x","article-title":"Understanding attitudes and obstacles to vaccination against COVID-19 in patients with primary immunodeficiency","volume":"18","author":"Aberumand","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2026100911163573100_iqag015-B17","doi-asserted-by":"publisher","first-page":"103239","DOI":"10.1016\/j.eclinm.2025.103239","article-title":"The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles","volume":"83","author":"Leston","year":"2025","journal-title":"EClinicalMed"},{"key":"2026100911163573100_iqag015-B18","author":"NIHR","year":"2025"},{"key":"2026100911163573100_iqag015-B19","author":"EULAR","year":"2024"},{"key":"2026100911163573100_iqag015-B20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-2482-0","volume-title":"The Craft of Scientific Writing","author":"Alley","year":"1996"},{"key":"2026100911163573100_iqag015-B21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"2026100911163573100_iqag015-B22","author":"UK policy framework for health and social care research. Health Research Authority","year":"2023"},{"key":"2026100911163573100_iqag015-B23","author":"Is my study research? Health Research Authority","year":"2022"},{"key":"2026100911163573100_iqag015-B24","author":"Defining Research","year":"2022"},{"key":"2026100911163573100_iqag015-B25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1370\/afm.2895","article-title":"Primary Care physicians\u2019 and patients\u2019 perspectives on equity and health security of infectious disease digital surveillance","volume":"21","author":"Wong","year":"2023","journal-title":". Ann Family Med"},{"key":"2026100911163573100_iqag015-B26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2105\/ajph.2023.307348","article-title":"Overcoming public health \u2018surveillance\u2019: when words matter","volume":"113","author":"Kassler","year":"2023","journal-title":"Am J Public Health"},{"key":"2026100911163573100_iqag015-B27","doi-asserted-by":"publisher","DOI":"10.33774\/coe-2020-kp6b4","article-title":"R0 we getting it? Misconceptions and misinterpretation of the basic reproduction number for CoVID-19","author":"Gaurav","year":"2020","journal-title":"Cambridge Open Engage"},{"key":"2026100911163573100_iqag015-B28","doi-asserted-by":"publisher","first-page":"114500","DOI":"10.1016\/j.socscimed.2021.114500","article-title":"Politicized disease surveillance: a theoretical lens for understanding sociopolitical influence on the surveillance of disease epidemics","volume":"291","author":"Fisher","year":"2021","journal-title":"Soc Sci Med"},{"key":"2026100911163573100_iqag015-B29","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41433-022-02050-1","article-title":"Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy","volume":"37","author":"Prior","year":"2023","journal-title":"Eye (Lond)"},{"key":"2026100911163573100_iqag015-B30","doi-asserted-by":"publisher","DOI":"10.1007\/s41666-025-00187-8","article-title":"Integrating the patient perspective into healthcare and real-world evidence: the multi-site, cross-disease, Patient-Centered Outcomes Research Project in the Medical Informatics Initiative (PCOR-MII)","author":"Rogge","year":"2025","journal-title":"J Healthc Inform Res"},{"key":"2026100911163573100_iqag015-B31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1197\/jamia.M2134","article-title":"The value of patient self-report for disease surveillance","volume":"14","author":"Bourgeois","year":"2007","journal-title":"J Am Med Inform Assoc"},{"key":"2026100911163573100_iqag015-B32","doi-asserted-by":"publisher","first-page":"100005","DOI":"10.1016\/j.focus.2022.100005","article-title":"Patient self-report superior to electronic medical record abstraction for identifying positive COVID-19 symptoms at illness onset","volume":"1","author":"Mockler","year":"2022","journal-title":"AJPM Focus"},{"key":"2026100911163573100_iqag015-B33","doi-asserted-by":"publisher","first-page":"107026","DOI":"10.1016\/j.imlet.2025.107026","article-title":"Mast cell activation signature as a potential biomarker in COVID-19","volume":"275","author":"Meneses-Preza","year":"2025","journal-title":"Immunol Lett"},{"key":"2026100911163573100_iqag015-B34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40900-026-00890-9","article-title":"Patient and public involvement and engagement in Long COVID research: embedding inclusion in research","volume":"12","author":"Skipper","year":"2026","journal-title":"Res Involv Engagem"},{"key":"2026100911163573100_iqag015-B35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12981-023-00585-1","article-title":"Addressing HIV stigma in healthcare, community, and legislative settings in Central and Eastern Europe","volume":"20","author":"Schweitzer","year":"2023","journal-title":"Aids Res Ther"},{"key":"2026100911163573100_iqag015-B36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.mayocp.2020.06.058","article-title":"Disparities in research participation by level of health literacy","volume":"96","author":"Kripalani","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2026100911163573100_iqag015-B37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/10242694.2018.1465676","article-title":"Patient engagement in VA health care: does gender play a role?","volume":"31","author":"Etingen","year":"2023","journal-title":"Def Peace Econ"},{"key":"2026100911163573100_iqag015-B38","author":"PrimDISC","year":"2024"}],"container-title":["Oxford Open Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ooim\/advance-article-pdf\/doi\/10.1093\/oxfimm\/iqag015\/71227933\/iqag015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ooim\/article-pdf\/7\/1\/iqag015\/71227933\/iqag015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ooim\/article-pdf\/7\/1\/iqag015\/71227933\/iqag015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:19:19Z","timestamp":1791559159000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ooim\/article\/doi\/10.1093\/oxfimm\/iqag015\/8817544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/oxfimm\/iqag015","relation":{},"ISSN":["2633-6960"],"issn-type":[{"value":"2633-6960","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"iqag015"}}